Passi Healthcom Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-01-2025
- Paid Up Capital ₹ 0.10 M
as on 07-01-2025
- Company Age 34 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.50 Cr
as on 07-01-2025
- Revenue 46.92%
(FY 2022)
- Profit 1355.29%
(FY 2022)
- Ebitda 28.36%
(FY 2022)
- Net Worth 8.85%
(FY 2022)
- Total Assets -9.72%
(FY 2022)
About Passi Healthcom
The Corporate was formerly known as Passi Publications Private Limited. The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sarvesh Passi, Lucia Passi, and Ashish Kaushik serve as directors at the Company.
- CIN/LLPIN
U74899DL1990PTC039088
- Company No.
039088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 1990
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Passi Healthcom?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lucia Passi | Director | 05-Mar-1996 | Current |
Sarvesh Passi | Director | 01-Feb-1990 | Current |
Ashish Kaushik | Director | 04-Dec-2015 | Current |
Financial Performance of Passi Healthcom.
Passi Healthcom Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.92% increase. The company also saw a substantial improvement in profitability, with a 1355.29% increase in profit. The company's net worth moved up by a moderate rise of 8.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Passi Healthcom?
In 2019, Passi Healthcom had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cme Communications Private LimitedActive 31 years 1 month
Sarvesh Passi, Lucia Passi and 1 more are mutual person
- Passi Science Communications Private LimitedActive 23 years 7 months
Sarvesh Passi, Lucia Passi and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Icici Bank Limited Creation Date: 30 Jun 2015 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Passi Healthcom?
Unlock and access historical data on people associated with Passi Healthcom, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Passi Healthcom, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Passi Healthcom's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.